ISPE Announces Recipients of 2013 International Honor Awards at Global Annual Meeting
FOR IMMEDIATE RELEASE
ISPE Membership Marketing Communications Manager
Tel: +1-813-960-2105, ext. 277
Fax: +1 813.264.2816
ISPE Announces Recipients of 2013 International
Honor Awards at Global Annual Meeting
(TAMPA, FLORIDA, USA, 21 November 2013) – ISPE announced the recipients of its 2013
International Honor Awards at the Society’s Annual Meeting held in Washington, DC USA, 3 – 6 November.
Recognizing the awardees’ contributions to ISPE and to the pharmaceutical industry, Nancy S. Berg, President
and CEO, presented the honors on behalf of the ISPE Board of Directors.
“As a volunteer organization, ISPE depends on the dedicated work of its Members and the support of their
companies to achieve outcomes that make a difference in terms of industry best practices, product quality and
ultimately, patient health,” says Berg. “For that reason, recognizing Members and companies who make
contributions that raise the bar for the Society and for the industry is all-important. We are grateful for
their work on behalf of ISPE.”
The 2013 award winners are:
- Dr. John Berridge was honored with the Joseph X. Phillips Professional
Achievement Award, a special award that recognizes an ISPE Member who has made a significant
contribution to the pharmaceutical industry, not just ISPE. Named in honor of Joe Phillips, longtime
supporter of ISPE and a leader in establishing the Society as an “integrator” of industry and regulators both
during his years of service with the FDA and later when he became International Regulatory Affairs Advisor to
ISPE, this award is given infrequently to recognize the extraordinary contributions of its recipients.
- Jean-Francois Duliere of Technip France was awarded the Max Seales Yonker Member
of the Year Award, which recognizes a Member who has made significant contributions to ISPE in the
past 12 months. It is named in honor of a dynamic lady who contributed to the Society in many different ways
and served as a source of inspiration during her battle with cancer.
- Stephen Tyler of AbbVie and Winnie Cappucci, retired from Bayer
Healthcare, were both honored with the Richard B. Purdy Distinguished Achievement Award,
given in recognition of multiple years of dedicated service to ISPE. It is named after one of the Society’s
founders and most accomplished Presidents
- The Drug Shortages Initiative Team was named Committee of the Year.
This award recognizes the outstanding work of the Society’s committees, councils, task teams or community of
practice steering committees. This committee is chaired by François Sallans, Vice President and Chief Quality
Officer, Pharmaceutical, Johnson & Johnson.
- The ISPE Pacific Northwest Chapter and ISPE China were recognized with
the Affiliate and Chapter Excellence Award. This award recognizes the outstanding work of
one of ISPE’s International Affiliates and Chapters, as reflected by membership development and services,
management, industry and society support and innovation.
- Johnson & Johnson was named Company of the Year, an award that
honors outstanding support provided by a company as reflected in commitment to the mission of the
organization as well as through company employees’ significant active participation in the Society’s
committees, councils, task teams, COPs, programs and activities.
- Gordon Leichter, PhD and John Spohn, CPIP were awarded the
Roger F. Sherwood Article of the Year Award for their article, “Automating a Manual Cleaning
Program in a Multi-Product Biopharmaceutical Manufacturing Operation,” published in the January/February 2013
issue of Pharmaceutical Engineering
To read more about these Society leaders and the awards they received, and to view the complete list of
awards presented at the 2013 ISPE Annual Meeting, please visit the ISPE International Honor Awards page on the ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest
not-for-profit association serving its Members through leading scientific, technical and regulatory
advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions
in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical
delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide
headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit www.ISPE.org for more information.